A clinical stage biotechnology company focused on rare genetic skin diseases.
Total funding: $0
Technologies used by Dermelix Biotherapeutics
Get unlimited access to our company database — complete with detailed profiles, funding info, and tech stacks — and start sending personalized emails with AI-powered follow-ups.